Search This Blog

Monday, July 9, 2018

Dova cut to neutral by Leerink

Dova Pharmaceuticals downgraded to Market Perform from Outperform at Leerink 0
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)